{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:39Z","timestamp":1793299119370,"version":"4.5.0"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/aog.0b013e3181801d56","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:46:33Z","timestamp":1291103193000},"page":"359-372","source":"Crossref","is-referenced-by-count":235,"title":["Prediction and Prevention of Recurrent Preeclampsia"],"prefix":"10.1097","volume":"112","author":[{"given":"John R.","family":"Barton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210621","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia.","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"R2-26-20210621","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/0002-9378(91)90379-6","article-title":"Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis.","volume":"165","author":"Sibai","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R3-26-20210621","first-page":"159","article-title":"Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33 American College of Obstetricians and Gynecologists.","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R4-26-20210621","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R5-26-20210621","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0146-0005(03)00022-3","article-title":"National Institute of Child Health and Human Development Maternal\u2013Fetal Medicine Units Network. What we have learned about preeclampsia.","volume":"27","author":"Sibai","year":"2003","journal-title":"Semin Preinatol"},{"key":"R6-26-20210621","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006250-200212000-00037","article-title":"Chronic hypertension in pregnancy.","volume":"100","author":"Sibai","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R7-26-20210621","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.298.13.1548","article-title":"A 30-year-old woman with chronic hypertension trying to conceive.","volume":"298","author":"Powrie","year":"2007","journal-title":"JAMA"},{"key":"R8-26-20210621","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0002-9378(00)70225-0","article-title":"Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.","volume":"182","author":"Sibai","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R9-26-20210621","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1471-0528.2006.01071.x","article-title":"Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes.","volume":"113","author":"Temple","year":"2006","journal-title":"BJOG"},{"key":"R10-26-20210621","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/bmj.38043.583160.EE","article-title":"Risk of complications of pregnancy in women with type I diabetes: nationwide prospective study in the Netherlands.","volume":"328","author":"Evers","year":"2004","journal-title":"BMJ"},{"key":"R11-26-20210621","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/01.AOG.0000126279.87151.e1","article-title":"Association of rheumatologic disease with preeclampsia [published erratum appears in Obstet Gynecol 2005;105:222].","volume":"103","author":"Wolfberg","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R12-26-20210621","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.rdc.2007.02.002","article-title":"Management of the high-risk lupus pregnant patient.","volume":"33","author":"Witter","year":"2007","journal-title":"Rheum Dis Clin N Am"},{"key":"R13-26-20210621","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.AOG.0000146250.85561.e9","article-title":"Genetic thrombophilias and preeclampsia: a meta-analysis.","volume":"105","author":"Lin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R14-26-20210621","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/01.grf.0000211954.66959.e1","article-title":"Thrombophilia and adverse maternal-perinatal outcome.","volume":"49","author":"Stella","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"R15-26-20210621","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.AOG.0000253311.44696.85","article-title":"Management of obesity in pregnancy.","volume":"109","author":"Catalano","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R16-26-20210621","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.fertnstert.2006.11.131","article-title":"Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestations.","volume":"88","author":"Hern\u00e1ndez-D\u00edaz","year":"2007","journal-title":"Fertil Steril"},{"key":"R17-26-20210621","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajog.2003.12.003","article-title":"Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies.","volume":"191","author":"Wen","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R18-26-20210621","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/14767050500246045","article-title":"Preeclampsia in twin gestations: Association with IVF treatments, parity and maternal age.","volume":"19","author":"Erez","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R19-26-20210621","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(02)07804-2","article-title":"Surgically obtained sperm and risk of gestational hypertension and preeclampsia.","volume":"359","author":"Wang","year":"2002","journal-title":"Lancet"},{"key":"R20-26-20210621","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejogrb.2006.02.019","article-title":"Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia.","volume":"128","author":"Rig\u00f3","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R21-26-20210621","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1471-0528.2006.01231.x","article-title":"Being born small for gestational age increases the risk of severe preeclampsia.","volume":"114","author":"Zetterstr\u00f6m","year":"2007","journal-title":"BJOG"},{"key":"R22-26-20210621","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.316.7141.1343","article-title":"Fetal and maternal contributions to risk of preeclampsia: a population based study.","volume":"316","author":"Lie","year":"1998","journal-title":"BMJ"},{"key":"R23-26-20210621","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa031587","article-title":"Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth.","volume":"350","author":"Surkan","year":"2004","journal-title":"N Engl J Med"},{"key":"R24-26-20210621","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1471-0528.2007.01562.x","article-title":"Obstetric outcomes subsequent to intrauterine death in the first pregnancy.","volume":"115","author":"Black","year":"2008","journal-title":"BJOG"},{"key":"R25-26-20210621","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1081\/PRG-100100133","article-title":"Obstetric prognosis in second pregnancy after preeclampsia in first pregnancy.","volume":"19","author":"Makkonen","year":"2000","journal-title":"Hypertens Pregnancy"},{"key":"R26-26-20210621","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1067\/mob.2002.120280","article-title":"Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas [published erratum appears in Am J Obstet Gynecol 2003;189:244].","volume":"186","author":"Hnat","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R27-26-20210621","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajmg.a.20512","article-title":"Recurrence risk of preeclampsia in twin and singleton pregnancies.","volume":"126A","author":"Trogstad","year":"2004","journal-title":"Am J Med Genet A"},{"key":"R28-26-20210621","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(06)68433-X","article-title":"Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.","volume":"367","author":"Poston","year":"2006","journal-title":"Lancet"},{"key":"R29-26-20210621","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ajog.2005.10.819","article-title":"Recurrence of hypertensive disorder in second pregnancy.","volume":"194","author":"Hjartardottir","year":"2006","journal-title":"Am J Obset Gynecol"},{"key":"R30-26-20210621","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1471-0528.2007.01376.x","article-title":"Can we predict recurrence of pre-eclampsia or gestational hypertension?","volume":"114","author":"Brown","year":"2007","journal-title":"BJOG"},{"key":"R31-26-20210621","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.AOG.0000289576.43441.1f","article-title":"Antioxidant therapy to prevent preeclampsia: a randomised controlled trial.","volume":"110","author":"Spinnato","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R32-26-20210621","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ajog.2007.10.009","article-title":"WHO randomised trial of vitamin C & E supplementation among women at high risk for preeclampsia and nutritional deficiency.","volume":"197","author":"Villar","year":"2007","journal-title":"Am J Obset Gynecol"},{"key":"R33-26-20210621","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ajog.2006.06.044","article-title":"Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia.","volume":"195","author":"van Rijn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R34-26-20210621","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.AOG.0000152351.13671.99","article-title":"Diagnosis, prevention, and management of eclampsia.","volume":"105","author":"Sibai","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R35-26-20210621","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R36-26-20210621","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1469-0705.2002.00822.x","article-title":"A case of partial mole and atypical type 1 triploidy associated with severe HELLP syndrome at 18 weeks\u2019 gestation.","volume":"20","author":"Stefos","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R37-26-20210621","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2006-934093","article-title":"Acute onset of severe hemolysis, elevated liver enzymes, and low platelet count syndrome in a patient with a partial hydatidiform mole at 17 weeks gestation.","volume":"23","author":"Sherer","year":"2006","journal-title":"Am J Perinatol"},{"key":"R38-26-20210621","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0960-7692.2001.00470.x","article-title":"Twin chorionicity and pre-eclampsia.","volume":"18","author":"Savvidou","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R39-26-20210621","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2007-994140","article-title":"The rate of severe preeclampsia is increased in triplet as compared to twin gestations.","volume":"14","author":"Mastrobattista","year":"1997","journal-title":"Am J Perinatol"},{"key":"R40-26-20210621","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1067\/mob.2001.117352","article-title":"Relationship of twin zygosity and risk of preeclampsia.","volume":"185","author":"Maxwell","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R41-26-20210621","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0002-9378(00)70350-4","article-title":"Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.","volume":"182","author":"Sibai","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R42-26-20210621","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14767050701483298","article-title":"CXCL10\/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia.","volume":"20","author":"Gotsch","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R43-26-20210621","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1067\/mob.2001.112905","article-title":"Mild gestational hypertension remote from term: progression and outcome.","volume":"184","author":"Barton","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R44-26-20210621","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-0528.1998.tb09971.x","article-title":"Does gestational hypertension become pre-eclampsia?","volume":"105","author":"Saudan","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R45-26-20210621","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1701-2163(16)30579-5","article-title":"Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study.","volume":"25","author":"Magee","year":"2003","journal-title":"J Obstet Gynecol Can"},{"key":"R46-26-20210621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajog.2007.07.040","article-title":"Maternal infection and risk of preeclampsia: systematic review and metaanalysis.","volume":"198","author":"Conde-Agudelo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R47-26-20210621","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [published erratum appears in N Engl J Med 2006;355:1840].","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"R48-26-20210621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdrc.20119","article-title":"Tobacco and pregnancy: overview of exposures and effects.","volume":"84","author":"Rogers","year":"2008","journal-title":"Birth Defects Res C Embryo Today"},{"key":"R49-26-20210621","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.AOG.0000147599.47713.5d","article-title":"World Health Organization systematic review of screening tests for preeclampsia [published erratum appears in Obstet Gynecol 2005;106:869].","volume":"104","author":"Conde-Agudelo","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R50-26-20210621","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","article-title":"Mapping the theories of preeclampsia and the role of angiogenic factors: A systemic review.","volume":"109","author":"Widmer","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R51-26-20210621","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia.","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"R52-26-20210621","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R53-26-20210621","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R54-26-20210621","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"key":"R55-26-20210621","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajog.2007.03.058","article-title":"Soluble endoglin as a second-trimester marker for preeclampsia.","volume":"197","author":"Robinson","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R56-26-20210621","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajog.2007.05.022","article-title":"Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.","volume":"197","author":"Unal","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R57-26-20210621","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women.","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R58-26-20210621","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","article-title":"Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.","volume":"361","author":"Savvidou","year":"2003","journal-title":"Lancet"},{"key":"R59-26-20210621","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ajog.2007.05.052","article-title":"Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants.","volume":"198","author":"Speer","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R60-26-20210621","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R61-26-20210621","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1471-0528.2000.tb11690.x","article-title":"How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, intrauterine growth retardation and prenatal death? An overview.","volume":"107","author":"Chien","year":"2000","journal-title":"BJOG"},{"key":"R62-26-20210621","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of preeclampsia in women with abnormal uterine artery Doppler at 23 weeks\u2019 gestation.","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R63-26-20210621","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1469-0705.2002.00865.x","article-title":"Screening for preeclampsia and fetal growth restriction in twin pregnancies at 23 weeks of gestation by transvaginal uterine artery Doppler ultrasound.","volume":"20","author":"Yu","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R64-26-20210621","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/00016340601155056","article-title":"Screening for pre-eclampsia and small for gestational age fetuses at the 11\u201314 weeks scan by uterine artery Dopplers.","volume":"86","author":"Pilalis","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R65-26-20210621","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1469-0705.2002.00866.x","article-title":"Doppler assessment of the uterine circulation in the second trimester in twin pregnancies: prediction of preeclampsia, fetal growth restriction and birth weight discordance.","volume":"20","author":"Geipel","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R66-26-20210621","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/GCO.0b013e32809bd964","article-title":"Uterine artery Doppler in the prediction of adverse pregnancy outcome.","volume":"19","author":"Papageorghiou","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R67-26-20210621","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1469-0705.2001.00382.x","article-title":"Improved early prediction of preeclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler.","volume":"17","author":"Aquilina","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R68-26-20210621","first-page":"326","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor [published erratum appears in Am J Obstet Gynecol 2007;196:614].","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R69-26-20210621","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"R70-26-20210621","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(06)69473-7","article-title":"Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study.","volume":"368","author":"Villamor","year":"2006","journal-title":"Lancet"},{"key":"R71-26-20210621","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2105\/AJPH.91.3.436","article-title":"Pregnancy complications and outcomes among overweight and obese nulliparous women.","volume":"91","author":"Baeten","year":"2001","journal-title":"Am J Public Health"},{"key":"R72-26-20210621","first-page":"CD003402","article-title":"Marine oil and other prostaglandin precursor supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth retardation.","volume":"3","author":"Makrides","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R73-26-20210621","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.","volume":"1","author":"Abalos","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R74-26-20210621","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1471-0528.2007.01389.x","article-title":"Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and a commentary.","volume":"114","author":"Hofmeyr","year":"2007","journal-title":"BJOG"},{"key":"R75-26-20210621","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data.","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"R76-26-20210621","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1471-0528.2000.tb13235.x","article-title":"Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) Team.","volume":"107","author":"Olsen","year":"2000","journal-title":"BJOG"},{"key":"R77-26-20210621","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1471-0528.2006.00826.x","article-title":"Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy.","volume":"113","author":"Olafsdottir","year":"2006","journal-title":"BJOG"},{"key":"R78-26-20210621","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1753-4887.2007.tb00284.x","article-title":"Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration.","volume":"65","author":"Trumbo","year":"2007","journal-title":"Nutr Rev"},{"key":"R79-26-20210621","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.gco.0000247393.86968.e6","article-title":"New therapies in the prevention of preeclampsia.","volume":"18","author":"Spinnato","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R80-26-20210621","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial.","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"key":"R81-26-20210621","first-page":"1119","article-title":"Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.","volume":"83","author":"Vainio","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R82-26-20210621","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajog.2007.02.030","article-title":"Subgroup analysis in obstetrics clinical trials.","volume":"197","author":"Klebanoff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R83-26-20210621","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent.","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R84-26-20210621","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1479-828X.1995.tb02141.x","article-title":"Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.","volume":"35","author":"North","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R85-26-20210621","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias.","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"R86-26-20210621","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10641950600745517","article-title":"Prophylaxis of recurrent preeclampsia: Low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone.","volume":"25","author":"Sergio","year":"2006","journal-title":"Hypertens Pregnancy"},{"key":"R87-26-20210621","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006250-200511000-00056","article-title":"Antiphospholipid syndrome. ACOG Practice Bulletin No. 68. American College of Obstetricians and Gynecologists.","volume":"106","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R88-26-20210621","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/01.AOG.0000267203.55718.aa","article-title":"Prevention of recurrent fetal growth restriction.","volume":"110","author":"Berghella","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R89-26-20210621","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0301-2115(95)02189-E","article-title":"Uterine Doppler wave form and the prediction of the recurrence of pre-eclampsia and intra-uterine growth retardation in patients treated with low-dose aspirin.","volume":"62","author":"Haddad","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R90-26-20210621","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.0001-6349.2004.00424.x","article-title":"Recurrent preeclampsia and perinatal outcome: a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies.","volume":"83","author":"Mendilcioglu","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R91-26-20210621","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications.","volume":"196","author":"Sibai","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200808000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:20Z","timestamp":1786041620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200808000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181801d56","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}